ARTL Stock Analysis: Buy, Sell, or Hold?
ARTL - Artelo Biosciences, Inc. Common Stock
$7.50
-3.04 (-28.80%)
▼
5d:
-2.03%
30d:
+530.61%
90d:
+403.64%
WAIT
LOW Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 12, 2026
Get Alerted When ARTL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ARTL is 24.9% above fair value ($6.01). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ARTL is 24.9% above fair value ($6.01). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: ARTL is currently trading at $7.50, which is considered extended relative to its 30-day fair value range of $0.71 to $6.01.
Technical Outlook: Technically, ARTL is in a uptrend. Immediate support is located at $2.96, while resistance sits at $14.96. Short-term momentum is weak, with the stock down 28.8% recently.
Market Sentiment: ARTL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $18.00 (+70.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ARTL is in a uptrend. Immediate support is located at $2.96, while resistance sits at $14.96. Short-term momentum is weak, with the stock down 28.8% recently.
Market Sentiment: ARTL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $18.00 (+70.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$0.71 -
$6.01
Company Quality Score
50/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
42.1%
All Signals
- BEARISH: Price significantly overextended (+24.9% above fair value)
- BULLISH: Strong technical setup (60/100)
- BEARISH: Downward momentum (-28.8%)
- BULLISH: Trading 70.8% below Wall St target ($18.00)
Fair Price Analysis
30-Day Fair Range
$0.71 -
$6.01
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$2.96
Resistance Level
$14.96
Current Trend
Uptrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.21
Wall Street Target
$18.00
(+70.8%)
Share & Embed Analysis
Last updated: March 30, 2026 10:01 AM ET
Data refreshes hourly during market hours. Next update: 11:01 AM
Data refreshes hourly during market hours. Next update: 11:01 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARTL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 62 BUY |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 62 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 61 BUY |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 63 BUY |
